GlassScriptPhysician profile
Charles Marshall Webb
NPI 1982678736
$1,392.13
in general payments reported to CMS, 2019-2025
22 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $65.50 · 2021: $128 · 2022: $188 · 2023: $234 · 2024: $221 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418 · Travel and Lodging: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.83 |
| Travel and Lodging | $178.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $323.34 | 2021-2023 | Da Vinci Surgical System |
| Abbvie INC. | $161.68 | 2019-2024 | |
| Organon LLC | $144.35 | 2021-2025 | Nexplanon |
| Axsome Therapeutics, INC. | $98.18 | 2025 | Auvelity |
| Angiodynamics, INC. | $97.69 | 2019 | |
| Medtronic, INC. | $74.08 | 2021-2024 | Mazor X System |
| Merck Sharp & Dohme LLC | $54.81 | 2019-2020 | |
| Biogen, INC. | $54.59 | 2024 | Zurzuvae |
| Daiichi Sankyo INC. | $49.78 | 2019-2022 | |
| Exeltis, USA INC. | $46.85 | 2024 | Slynd |
| Pfizer INC. | $46.09 | 2019-2022 | |
| Coopersurgical, INC. | $41.30 | 2019-2020 | |
| Hologic Sales and Service, LLC | $40.85 | 2022-2025 | Aptima |
| Novo Nordisk INC | $34.48 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $23.45 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $22.31 | 2019-2020 | |
| Aspira Women'S Health INC | $16.74 | 2020 | |
| Baxter Healthcare | $14.79 | 2024 | Perclot |
| Coloplast Corp | $12.82 | 2023 | Altis |
| Myovant Sciences INC. | $11.55 | 2021 | |
| Duchesnay USA Incorporated | $11.43 | 2019 | |
| Mission Pharmacal Company | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.